Yüklüyor......
Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one
Statins are promising anticancer agents that target the mevalonate pathway. Tumor cells are sensitive to depletion of mevalonate-derived products but this activity triggers a homeostatic feedback loop that blunts statin efficacy. We showed that dipyridamole inhibits this feedback response and potent...
Kaydedildi:
| Yayımlandı: | Mol Cell Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905210/ https://ncbi.nlm.nih.gov/pubmed/27308369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723548.2014.969133 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|